Navigation Links
RI Hospital: Absence of specific enzyme in cartilage can lead to benign tumors in mice
Date:7/18/2013

PROVIDENCE, R.I. Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis. Shp2 is an enzyme in the cell that regulates the activity of other proteins and signaling pathways. Mice lacking Shp2 formed two types of tumors: enchondromas and osteochondromas, and also developed deformed joints. The study is published online in advance of print in the journal Nature.

"Transgenic mouse models of human disease are powerful tools to gain a better understanding of disease processes and to test novel treatments," said lead author, Wentian Yang, Ph.D., of the department of orthopedics at Rhode Island Hospital. "In humans, some of these benign tumors will progress to malignant cartilage tumors, called chondrosarcomas, which are even more serious since they spread and can be fatal."

He continued, "Knowing the cell of origin for tumor formation can be helpful in developing new treatments since each type of cell has its weak points. Our research led to the discovery of a novel cartilage stem/progenitor cell population that is the cell of origin for the tumors in our model, and to the identification of a potential therapy for this rare disease. In the future, our model may also be useful for developing novel treatments for some forms of chondrosarcoma, a type of bone cancer."

Injury to the growth plate has been the assumed reason for the formation of osteochondromas, which look similar to a growth plate that has taken off in the wrong direction, causing bone and cartilage to grow out of the bone. This research demonstrates that one cause of osteochondromas is a molecular abnormality in an enzyme in a tiny group of cells near the growth plate, resulting in often large tumors growing out of the bone. These tumors are a very common in children.

"These findings put us one step closer to understanding how these tumors form," Yang said. "The next step will be to develop a way to stop the tumors from growing at an early stage so that they do not have to be surgically removed."


'/>"/>

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan
Source:Eurekalert

Related biology news :

1. Rhode Island Hospital: Adult entertainment workers likely to benefit from health care intervention
2. RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
3. Viable and fertile fruit flies in the absence of histone H3.3
4. The absence of elephants and rhinoceroses reduces biodiversity in tropical forests
5. Researchers create method to rapidly identify specific strains of illness
6. Epigenetic biomarkers may predict if a specific diet and exercise regimen will work
7. Turtle genome analysis sheds light on the development and evolution of turtle-specific body plan
8. Cutting specific pollutants would slow sea level rise
9. In autism, age at diagnosis depends on specific symptoms
10. Molecular basis identified for tissue specific immune regulation in the eye and kidney
11. Bisphenol A affects sex-specific reproductive behaviors in a monogamous animal species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... ... accelerate pharmaceutical and biotherapeutics development, announces the launch of the new NHS ... to gain kinetic binding data for a wide range of molecules, including small ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... The ... time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. ... February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our ...
(Date:8/14/2017)... Portland, Oregon (PRWEB) , ... August 14, 2017 ... ... modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... hardware. , SYZYGY is intended to satisfy the need for a compact, low ...
(Date:8/11/2017)... ... ... Algenist continues to disrupt the skincare industry with today’s debut of GENIUS Liquid ... the key structural element skin needs to maintain its youthful appearance and Algenist is ... First to market with proprietary collagen water active , Active ...
Breaking Biology Technology: